Product Information
SEVELAMER HCL 800 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.7025 per EA under NDC 00904720906. Its NADAC has been published 78 times since Feb 26, 2025.
FDA first approved this application on Feb 8, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
800 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904720906
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
PARENTERAL
Effective Date
8/19/2026
Active Ingredients
SEVELAMER HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204724FDA Approved
2/8/2019
TE Code
AB
On Market Since
8/19/2024
Pharmacological Classes
Price Statistics
The NADAC for SEVELAMER HCL 800 MG TABLET has been published 78 times since Feb 26, 2025, and over the history we have for it it has declined 45.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7025 per EA |
|---|---|
| All-time high | $1.3679 (Sep 10, 2025) |
| All-time low | $0.7025 (Aug 19, 2026) |
| 52-week high | $1.3679 |
| 52-week low | $0.7025 |
| Median price | $1.1181 |
| Average price | $1.0748 |
| Largest weekly change | -11.4% (Nov 19, 2025) |
| Weeks tracked | 78 |
| Tracking since | Feb 26, 2025 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of SEVELAMER HCL 800 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SEVELAMER HCL 800 MG TABLET, manufactured by Major Pharmaceuticals, is $0.7025 per EA (NDC 00904720906), effective Aug 19, 2026.
How has the price of SEVELAMER HCL 800 MG TABLET changed over time?
Over the history we have for it, the NADAC for SEVELAMER HCL 800 MG TABLET has declined 45.6%. It has been tracked across 78 weekly CMS publications since Feb 26, 2025.
What are the highest and lowest recorded NADAC prices for SEVELAMER HCL 800 MG TABLET?
Since Feb 26, 2025, the NADAC for SEVELAMER HCL 800 MG TABLET has ranged from a low of $0.7025 (Aug 19, 2026) to a high of $1.3679 (Sep 10, 2025), with a median of $1.1181 per EA.
Are there cheaper alternatives to SEVELAMER HCL 800 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as SEVELAMER HCL 800 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures SEVELAMER HCL 800 MG TABLET?
SEVELAMER HCL 800 MG TABLET (NDC 00904720906) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.